nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ALB—acquired immunodeficiency syndrome	0.167	1	CbGaD
Glyburide—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0259	0.0415	CbGbCtD
Glyburide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0256	0.041	CbGbCtD
Glyburide—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.024	0.0384	CbGbCtD
Glyburide—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0237	0.038	CbGbCtD
Glyburide—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0224	0.0358	CbGbCtD
Glyburide—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.02	0.032	CbGbCtD
Glyburide—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0196	0.0314	CbGbCtD
Glyburide—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0196	0.0314	CbGbCtD
Glyburide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0194	0.0311	CbGbCtD
Glyburide—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0194	0.031	CbGbCtD
Glyburide—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0175	0.0281	CbGbCtD
Glyburide—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0175	0.0281	CbGbCtD
Glyburide—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0166	0.0265	CbGbCtD
Glyburide—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0146	0.0233	CbGbCtD
Glyburide—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0145	0.0233	CbGbCtD
Glyburide—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0145	0.0233	CbGbCtD
Glyburide—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0145	0.0233	CbGbCtD
Glyburide—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0131	0.021	CbGbCtD
Glyburide—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0131	0.021	CbGbCtD
Glyburide—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0126	0.0202	CbGbCtD
Glyburide—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0108	0.0173	CbGbCtD
Glyburide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0102	0.0163	CbGbCtD
Glyburide—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00975	0.0156	CbGbCtD
Glyburide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00911	0.0146	CbGbCtD
Glyburide—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00906	0.0145	CbGbCtD
Glyburide—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00869	0.0139	CbGbCtD
Glyburide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00857	0.0137	CbGbCtD
Glyburide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00789	0.0126	CbGbCtD
Glyburide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00775	0.0124	CbGbCtD
Glyburide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00775	0.0124	CbGbCtD
Glyburide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00758	0.0121	CbGbCtD
Glyburide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00712	0.0114	CbGbCtD
Glyburide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00712	0.0114	CbGbCtD
Glyburide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00691	0.0111	CbGbCtD
Glyburide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00669	0.0107	CbGbCtD
Glyburide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00649	0.0104	CbGbCtD
Glyburide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00644	0.0103	CbGbCtD
Glyburide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00644	0.0103	CbGbCtD
Glyburide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00625	0.01	CbGbCtD
Glyburide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00587	0.0094	CbGbCtD
Glyburide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00587	0.0094	CbGbCtD
Glyburide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00563	0.00901	CbGbCtD
Glyburide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00556	0.0089	CbGbCtD
Glyburide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0054	0.00864	CbGbCtD
Glyburide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0054	0.00864	CbGbCtD
Glyburide—CFTR—semen—acquired immunodeficiency syndrome	0.00539	0.0934	CbGeAlD
Glyburide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00524	0.00839	CbGbCtD
Glyburide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00488	0.00781	CbGbCtD
Glyburide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00488	0.00781	CbGbCtD
Glyburide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00474	0.00758	CbGbCtD
Glyburide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00474	0.00758	CbGbCtD
Glyburide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00468	0.00749	CbGbCtD
Glyburide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00454	0.00727	CbGbCtD
Glyburide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00441	0.00705	CbGbCtD
Glyburide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00414	0.00663	CbGbCtD
Glyburide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00414	0.00663	CbGbCtD
Glyburide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00375	0.006	CbGbCtD
Glyburide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00375	0.006	CbGbCtD
Glyburide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00351	0.00562	CbGbCtD
Glyburide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00323	0.00518	CbGbCtD
Glyburide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00314	0.00502	CbGbCtD
Glyburide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00284	0.00454	CbGbCtD
Glyburide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00284	0.00454	CbGbCtD
Glyburide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00272	0.00436	CbGbCtD
Glyburide—CPT1A—blood plasma—acquired immunodeficiency syndrome	0.00223	0.0387	CbGeAlD
Glyburide—ABCA1—blood plasma—acquired immunodeficiency syndrome	0.00208	0.036	CbGeAlD
Glyburide—KCNJ5—lymphoid tissue—acquired immunodeficiency syndrome	0.00158	0.0273	CbGeAlD
Glyburide—KCNJ5—lung—acquired immunodeficiency syndrome	0.0013	0.0225	CbGeAlD
Glyburide—KCNJ5—nervous system—acquired immunodeficiency syndrome	0.0012	0.0209	CbGeAlD
Glyburide—KCNJ5—central nervous system—acquired immunodeficiency syndrome	0.00116	0.0201	CbGeAlD
Glyburide—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0178	CbGeAlD
Glyburide—ABCA1—skin of body—acquired immunodeficiency syndrome	0.001	0.0173	CbGeAlD
Glyburide—ABCC9—lung—acquired immunodeficiency syndrome	0.000985	0.0171	CbGeAlD
Glyburide—KCNJ5—brain—acquired immunodeficiency syndrome	0.00092	0.0159	CbGeAlD
Glyburide—CPT1A—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000885	0.0983	CbGpPWpGaD
Glyburide—CPT1A—digestive system—acquired immunodeficiency syndrome	0.000858	0.0149	CbGeAlD
Glyburide—CPT1A—blood—acquired immunodeficiency syndrome	0.000818	0.0142	CbGeAlD
Glyburide—ABCA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000809	0.014	CbGeAlD
Glyburide—ABCA1—digestive system—acquired immunodeficiency syndrome	0.0008	0.0139	CbGeAlD
Glyburide—ABCA1—blood—acquired immunodeficiency syndrome	0.000762	0.0132	CbGeAlD
Glyburide—CPT1A—vagina—acquired immunodeficiency syndrome	0.000758	0.0131	CbGeAlD
Glyburide—CFTR—digestive system—acquired immunodeficiency syndrome	0.000755	0.0131	CbGeAlD
Glyburide—ABCA1—spinal cord—acquired immunodeficiency syndrome	0.000734	0.0127	CbGeAlD
Glyburide—CFTR—blood—acquired immunodeficiency syndrome	0.00072	0.0125	CbGeAlD
Glyburide—CPT1A—lung—acquired immunodeficiency syndrome	0.000717	0.0124	CbGeAlD
Glyburide—ABCA1—vagina—acquired immunodeficiency syndrome	0.000706	0.0122	CbGeAlD
Glyburide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000704	0.0122	CbGeAlD
Glyburide—ABCC9—brain—acquired immunodeficiency syndrome	0.000697	0.0121	CbGeAlD
Glyburide—ABCC9—lymph node—acquired immunodeficiency syndrome	0.000674	0.0117	CbGeAlD
Glyburide—ABCA1—lung—acquired immunodeficiency syndrome	0.000668	0.0116	CbGeAlD
Glyburide—KCNJ1—nervous system—acquired immunodeficiency syndrome	0.00065	0.0113	CbGeAlD
Glyburide—CFTR—lung—acquired immunodeficiency syndrome	0.000631	0.0109	CbGeAlD
Glyburide—KCNJ1—central nervous system—acquired immunodeficiency syndrome	0.000626	0.0108	CbGeAlD
Glyburide—ABCB11—digestive system—acquired immunodeficiency syndrome	0.00062	0.0107	CbGeAlD
Glyburide—ABCA1—nervous system—acquired immunodeficiency syndrome	0.000618	0.0107	CbGeAlD
Glyburide—ABCA1—central nervous system—acquired immunodeficiency syndrome	0.000595	0.0103	CbGeAlD
Glyburide—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000559	0.00968	CbGeAlD
Glyburide—ABCC8—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000547	0.0607	CbGpPWpGaD
Glyburide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000546	0.00946	CbGeAlD
Glyburide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00053	0.0589	CbGpPWpGaD
Glyburide—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.000516	0.00894	CbGeAlD
Glyburide—CPT1A—brain—acquired immunodeficiency syndrome	0.000507	0.00879	CbGeAlD
Glyburide—KCNJ1—brain—acquired immunodeficiency syndrome	0.000497	0.00861	CbGeAlD
Glyburide—CPT1A—lymph node—acquired immunodeficiency syndrome	0.00049	0.00849	CbGeAlD
Glyburide—ABCA1—brain—acquired immunodeficiency syndrome	0.000473	0.00819	CbGeAlD
Glyburide—ABCA1—lymph node—acquired immunodeficiency syndrome	0.000457	0.00791	CbGeAlD
Glyburide—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000449	0.00778	CbGeAlD
Glyburide—CFTR—brain—acquired immunodeficiency syndrome	0.000446	0.00774	CbGeAlD
Glyburide—ABCC8—spinal cord—acquired immunodeficiency syndrome	0.000431	0.00747	CbGeAlD
Glyburide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000416	0.00721	CbGeAlD
Glyburide—SLC15A2—retina—acquired immunodeficiency syndrome	0.0004	0.00692	CbGeAlD
Glyburide—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000396	0.00687	CbGeAlD
Glyburide—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000394	0.00683	CbGeAlD
Glyburide—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.000394	0.00683	CbGeAlD
Glyburide—CPT1A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000389	0.0432	CbGpPWpGaD
Glyburide—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.00038	0.00658	CbGeAlD
Glyburide—ABCC3—blood—acquired immunodeficiency syndrome	0.000376	0.00651	CbGeAlD
Glyburide—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.000367	0.00637	CbGeAlD
Glyburide—ABCA1—HDL-mediated lipid transport—ALB—acquired immunodeficiency syndrome	0.000365	0.0406	CbGpPWpGaD
Glyburide—ABCC8—nervous system—acquired immunodeficiency syndrome	0.000363	0.00629	CbGeAlD
Glyburide—ABCC8—central nervous system—acquired immunodeficiency syndrome	0.00035	0.00606	CbGeAlD
Glyburide—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000338	0.00586	CbGeAlD
Glyburide—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.000337	0.00584	CbGeAlD
Glyburide—SLC22A7—brain—acquired immunodeficiency syndrome	0.00033	0.00572	CbGeAlD
Glyburide—ABCC3—lung—acquired immunodeficiency syndrome	0.000329	0.00571	CbGeAlD
Glyburide—SLC22A6—brain—acquired immunodeficiency syndrome	0.000319	0.00552	CbGeAlD
Glyburide—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000315	0.00546	CbGeAlD
Glyburide—SLCO2B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000311	0.0345	CbGpPWpGaD
Glyburide—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.00031	0.00538	CbGeAlD
Glyburide—SLCO2B1—lung—acquired immunodeficiency syndrome	0.000307	0.00532	CbGeAlD
Glyburide—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000305	0.00528	CbGeAlD
Glyburide—KCNJ11—brain—acquired immunodeficiency syndrome	0.000301	0.00522	CbGeAlD
Glyburide—ABCC2—blood—acquired immunodeficiency syndrome	0.0003	0.0052	CbGeAlD
Glyburide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000295	0.0051	CbGeAlD
Glyburide—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.000294	0.00509	CbGeAlD
Glyburide—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.000291	0.00505	CbGeAlD
Glyburide—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.000284	0.00492	CbGeAlD
Glyburide—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000282	0.00489	CbGeAlD
Glyburide—ABCC8—brain—acquired immunodeficiency syndrome	0.000278	0.00481	CbGeAlD
Glyburide—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.000274	0.00474	CbGeAlD
Glyburide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000271	0.00469	CbGeAlD
Glyburide—SLC15A2—blood—acquired immunodeficiency syndrome	0.000267	0.00463	CbGeAlD
Glyburide—ABCC1—blood—acquired immunodeficiency syndrome	0.000264	0.00458	CbGeAlD
Glyburide—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000262	0.00453	CbGeAlD
Glyburide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000258	0.00447	CbGeAlD
Glyburide—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.000258	0.00446	CbGeAlD
Glyburide—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000252	0.00436	CbGeAlD
Glyburide—SLC15A2—vagina—acquired immunodeficiency syndrome	0.000248	0.00429	CbGeAlD
Glyburide—ABCC1—vagina—acquired immunodeficiency syndrome	0.000245	0.00425	CbGeAlD
Glyburide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000239	0.00414	CbGeAlD
Glyburide—SLC15A2—lung—acquired immunodeficiency syndrome	0.000234	0.00406	CbGeAlD
Glyburide—ABCC3—brain—acquired immunodeficiency syndrome	0.000233	0.00404	CbGeAlD
Glyburide—ABCC1—lung—acquired immunodeficiency syndrome	0.000232	0.00402	CbGeAlD
Glyburide—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000225	0.0039	CbGeAlD
Glyburide—ABCG2—blood—acquired immunodeficiency syndrome	0.000219	0.00379	CbGeAlD
Glyburide—SLCO2B1—brain—acquired immunodeficiency syndrome	0.000217	0.00376	CbGeAlD
Glyburide—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000217	0.00376	CbGeAlD
Glyburide—ABCA1—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000214	0.0237	CbGpPWpGaD
Glyburide—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000212	0.00367	CbGeAlD
Glyburide—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000211	0.00365	CbGeAlD
Glyburide—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.00021	0.00364	CbGeAlD
Glyburide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00021	0.00364	CbGeAlD
Glyburide—ABCA1—Lipoprotein metabolism—ALB—acquired immunodeficiency syndrome	0.00021	0.0233	CbGpPWpGaD
Glyburide—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.000209	0.00362	CbGeAlD
Glyburide—ABCG2—vagina—acquired immunodeficiency syndrome	0.000203	0.00352	CbGeAlD
Glyburide—CYP2C9—blood—acquired immunodeficiency syndrome	0.0002	0.00346	CbGeAlD
Glyburide—SLCO1A2—brain—acquired immunodeficiency syndrome	0.0002	0.00346	CbGeAlD
Glyburide—ALB—brain—acquired immunodeficiency syndrome	0.000199	0.00344	CbGeAlD
Glyburide—ALB—lymph node—acquired immunodeficiency syndrome	0.000192	0.00333	CbGeAlD
Glyburide—ABCG2—lung—acquired immunodeficiency syndrome	0.000192	0.00332	CbGeAlD
Glyburide—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000191	0.0212	CbGpPWpGaD
Glyburide—ABCC2—lymph node—acquired immunodeficiency syndrome	0.00018	0.00312	CbGeAlD
Glyburide—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000176	0.0196	CbGpPWpGaD
Glyburide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000172	0.00122	CcSEcCtD
Glyburide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000172	0.00122	CcSEcCtD
Glyburide—Shock—Indinavir—acquired immunodeficiency syndrome	0.000172	0.00122	CcSEcCtD
Glyburide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000172	0.00121	CcSEcCtD
Glyburide—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Glyburide—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Glyburide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Glyburide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Glyburide—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Glyburide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00017	0.0012	CcSEcCtD
Glyburide—ABCB11—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000169	0.0188	CbGpPWpGaD
Glyburide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000169	0.0012	CcSEcCtD
Glyburide—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000169	0.00119	CcSEcCtD
Glyburide—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.00119	CcSEcCtD
Glyburide—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00119	CcSEcCtD
Glyburide—ABCA1—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000168	0.0187	CbGpPWpGaD
Glyburide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000168	0.00119	CcSEcCtD
Glyburide—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00119	CcSEcCtD
Glyburide—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00118	CcSEcCtD
Glyburide—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00118	CcSEcCtD
Glyburide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000166	0.00118	CcSEcCtD
Glyburide—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00118	CcSEcCtD
Glyburide—SLC15A2—brain—acquired immunodeficiency syndrome	0.000166	0.00287	CbGeAlD
Glyburide—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.00117	CcSEcCtD
Glyburide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00117	CcSEcCtD
Glyburide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.00117	CcSEcCtD
Glyburide—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00116	CcSEcCtD
Glyburide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00116	CcSEcCtD
Glyburide—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00116	CcSEcCtD
Glyburide—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00116	CcSEcCtD
Glyburide—ABCC1—brain—acquired immunodeficiency syndrome	0.000164	0.00284	CbGeAlD
Glyburide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.00115	CcSEcCtD
Glyburide—ABCC3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000162	0.018	CbGpPWpGaD
Glyburide—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00115	CcSEcCtD
Glyburide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000162	0.00115	CcSEcCtD
Glyburide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.00115	CcSEcCtD
Glyburide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00114	CcSEcCtD
Glyburide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00114	CcSEcCtD
Glyburide—ABCB1—retina—acquired immunodeficiency syndrome	0.000161	0.0028	CbGeAlD
Glyburide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00114	CcSEcCtD
Glyburide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00016	0.00114	CcSEcCtD
Glyburide—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.00016	0.00278	CbGeAlD
Glyburide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.00113	CcSEcCtD
Glyburide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00016	0.00277	CbGeAlD
Glyburide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.00113	CcSEcCtD
Glyburide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.00113	CcSEcCtD
Glyburide—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00113	CcSEcCtD
Glyburide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000159	0.00113	CcSEcCtD
Glyburide—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.00113	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000159	0.00113	CcSEcCtD
Glyburide—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000159	0.00275	CbGeAlD
Glyburide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000158	0.00112	CcSEcCtD
Glyburide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000158	0.00112	CcSEcCtD
Glyburide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00112	CcSEcCtD
Glyburide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Glyburide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Glyburide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Glyburide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Glyburide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Glyburide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000156	0.0011	CcSEcCtD
Glyburide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000156	0.0011	CcSEcCtD
Glyburide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.0011	CcSEcCtD
Glyburide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.0011	CcSEcCtD
Glyburide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000155	0.0011	CcSEcCtD
Glyburide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.0011	CcSEcCtD
Glyburide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.00109	CcSEcCtD
Glyburide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00109	CcSEcCtD
Glyburide—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000154	0.0171	CbGpPWpGaD
Glyburide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00109	CcSEcCtD
Glyburide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.00109	CcSEcCtD
Glyburide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000154	0.00109	CcSEcCtD
Glyburide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.00109	CcSEcCtD
Glyburide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Glyburide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Glyburide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Glyburide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Glyburide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Glyburide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000152	0.00264	CbGeAlD
Glyburide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00108	CcSEcCtD
Glyburide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00108	CcSEcCtD
Glyburide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000152	0.00107	CcSEcCtD
Glyburide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00107	CcSEcCtD
Glyburide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000151	0.00107	CcSEcCtD
Glyburide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00107	CcSEcCtD
Glyburide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.00106	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.00106	CcSEcCtD
Glyburide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00106	CcSEcCtD
Glyburide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00106	CcSEcCtD
Glyburide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00106	CcSEcCtD
Glyburide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Glyburide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Glyburide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Glyburide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Glyburide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Glyburide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Glyburide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Glyburide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Glyburide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Glyburide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Glyburide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Glyburide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00103	CcSEcCtD
Glyburide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.00103	CcSEcCtD
Glyburide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.00103	CcSEcCtD
Glyburide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000144	0.00102	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00102	CcSEcCtD
Glyburide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00102	CcSEcCtD
Glyburide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00101	CcSEcCtD
Glyburide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00101	CcSEcCtD
Glyburide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00101	CcSEcCtD
Glyburide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000143	0.00101	CcSEcCtD
Glyburide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.00101	CcSEcCtD
Glyburide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00101	CcSEcCtD
Glyburide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.00101	CcSEcCtD
Glyburide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.001	CcSEcCtD
Glyburide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.001	CcSEcCtD
Glyburide—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000141	0.0157	CbGpPWpGaD
Glyburide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000998	CcSEcCtD
Glyburide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000998	CcSEcCtD
Glyburide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000997	CcSEcCtD
Glyburide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000995	CcSEcCtD
Glyburide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000994	CcSEcCtD
Glyburide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.000991	CcSEcCtD
Glyburide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000989	CcSEcCtD
Glyburide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000989	CcSEcCtD
Glyburide—ABCA1—Lipid and lipoprotein metabolism—ALB—acquired immunodeficiency syndrome	0.000139	0.0155	CbGpPWpGaD
Glyburide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000984	CcSEcCtD
Glyburide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000983	CcSEcCtD
Glyburide—ABCA1—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000139	0.0154	CbGpPWpGaD
Glyburide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000981	CcSEcCtD
Glyburide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000978	CcSEcCtD
Glyburide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000976	CcSEcCtD
Glyburide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000975	CcSEcCtD
Glyburide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000975	CcSEcCtD
Glyburide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000973	CcSEcCtD
Glyburide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000972	CcSEcCtD
Glyburide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000971	CcSEcCtD
Glyburide—ABCA1—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000137	0.0152	CbGpPWpGaD
Glyburide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000966	CcSEcCtD
Glyburide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000966	CcSEcCtD
Glyburide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000965	CcSEcCtD
Glyburide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000964	CcSEcCtD
Glyburide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000963	CcSEcCtD
Glyburide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000963	CcSEcCtD
Glyburide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000962	CcSEcCtD
Glyburide—ABCG2—brain—acquired immunodeficiency syndrome	0.000136	0.00235	CbGeAlD
Glyburide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000961	CcSEcCtD
Glyburide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.00096	CcSEcCtD
Glyburide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000135	0.000957	CcSEcCtD
Glyburide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000957	CcSEcCtD
Glyburide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000956	CcSEcCtD
Glyburide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000954	CcSEcCtD
Glyburide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000953	CcSEcCtD
Glyburide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000949	CcSEcCtD
Glyburide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000948	CcSEcCtD
Glyburide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000948	CcSEcCtD
Glyburide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000947	CcSEcCtD
Glyburide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000133	0.000943	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000941	CcSEcCtD
Glyburide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.00094	CcSEcCtD
Glyburide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.00094	CcSEcCtD
Glyburide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000933	CcSEcCtD
Glyburide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00093	CcSEcCtD
Glyburide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000929	CcSEcCtD
Glyburide—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000131	0.00227	CbGeAlD
Glyburide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000928	CcSEcCtD
Glyburide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000927	CcSEcCtD
Glyburide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000927	CcSEcCtD
Glyburide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000923	CcSEcCtD
Glyburide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000921	CcSEcCtD
Glyburide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.00092	CcSEcCtD
Glyburide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000917	CcSEcCtD
Glyburide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000913	CcSEcCtD
Glyburide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.00091	CcSEcCtD
Glyburide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000129	0.00091	CcSEcCtD
Glyburide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000909	CcSEcCtD
Glyburide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000909	CcSEcCtD
Glyburide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000128	0.000908	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000905	CcSEcCtD
Glyburide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000904	CcSEcCtD
Glyburide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000898	CcSEcCtD
Glyburide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000894	CcSEcCtD
Glyburide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000892	CcSEcCtD
Glyburide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000891	CcSEcCtD
Glyburide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000887	CcSEcCtD
Glyburide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000886	CcSEcCtD
Glyburide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000886	CcSEcCtD
Glyburide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000886	CcSEcCtD
Glyburide—ABCA1—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000125	0.0139	CbGpPWpGaD
Glyburide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000883	CcSEcCtD
Glyburide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000124	0.00214	CbGeAlD
Glyburide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000875	CcSEcCtD
Glyburide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000874	CcSEcCtD
Glyburide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000864	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000864	CcSEcCtD
Glyburide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.00086	CcSEcCtD
Glyburide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000858	CcSEcCtD
Glyburide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000851	CcSEcCtD
Glyburide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000851	CcSEcCtD
Glyburide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000845	CcSEcCtD
Glyburide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000845	CcSEcCtD
Glyburide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000844	CcSEcCtD
Glyburide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000844	CcSEcCtD
Glyburide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000119	0.00206	CbGeAlD
Glyburide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000837	CcSEcCtD
Glyburide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000837	CcSEcCtD
Glyburide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000837	CcSEcCtD
Glyburide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000835	CcSEcCtD
Glyburide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000832	CcSEcCtD
Glyburide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000826	CcSEcCtD
Glyburide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000824	CcSEcCtD
Glyburide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000823	CcSEcCtD
Glyburide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00082	CcSEcCtD
Glyburide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000819	CcSEcCtD
Glyburide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000819	CcSEcCtD
Glyburide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000816	CcSEcCtD
Glyburide—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000115	0.0128	CbGpPWpGaD
Glyburide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000813	CcSEcCtD
Glyburide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000115	0.00199	CbGeAlD
Glyburide—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000113	0.00196	CbGeAlD
Glyburide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000801	CcSEcCtD
Glyburide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000798	CcSEcCtD
Glyburide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.00079	CcSEcCtD
Glyburide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00079	CcSEcCtD
Glyburide—ABCA1—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000112	0.0124	CbGpPWpGaD
Glyburide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000789	CcSEcCtD
Glyburide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000786	CcSEcCtD
Glyburide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000785	CcSEcCtD
Glyburide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000781	CcSEcCtD
Glyburide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000779	CcSEcCtD
Glyburide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000778	CcSEcCtD
Glyburide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000775	CcSEcCtD
Glyburide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000774	CcSEcCtD
Glyburide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000764	CcSEcCtD
Glyburide—ABCB1—blood—acquired immunodeficiency syndrome	0.000108	0.00187	CbGeAlD
Glyburide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000761	CcSEcCtD
Glyburide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000753	CcSEcCtD
Glyburide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000749	CcSEcCtD
Glyburide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000742	CcSEcCtD
Glyburide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000741	CcSEcCtD
Glyburide—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000104	0.00181	CbGeAlD
Glyburide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000736	CcSEcCtD
Glyburide—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000104	0.0018	CbGeAlD
Glyburide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000735	CcSEcCtD
Glyburide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000734	CcSEcCtD
Glyburide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000732	CcSEcCtD
Glyburide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000731	CcSEcCtD
Glyburide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000731	CcSEcCtD
Glyburide—ABCA1—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000102	0.0113	CbGpPWpGaD
Glyburide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000713	CcSEcCtD
Glyburide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00071	CcSEcCtD
Glyburide—ABCB1—vagina—acquired immunodeficiency syndrome	0.0001	0.00173	CbGeAlD
Glyburide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.98e-05	0.000706	CcSEcCtD
Glyburide—Rash—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000704	CcSEcCtD
Glyburide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.94e-05	0.000703	CcSEcCtD
Glyburide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.94e-05	0.000703	CcSEcCtD
Glyburide—Headache—Delavirdine—acquired immunodeficiency syndrome	9.89e-05	0.0007	CcSEcCtD
Glyburide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000699	CcSEcCtD
Glyburide—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.8e-05	0.000693	CcSEcCtD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.71e-05	0.0108	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.71e-05	0.0108	CbGpPWpGaD
Glyburide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.00068	CcSEcCtD
Glyburide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.61e-05	0.00068	CcSEcCtD
Glyburide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	9.53e-05	0.0106	CbGpPWpGaD
Glyburide—KCNJ11—Type II diabetes mellitus—TNF—acquired immunodeficiency syndrome	9.51e-05	0.0106	CbGpPWpGaD
Glyburide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.48e-05	0.000671	CcSEcCtD
Glyburide—ABCB1—lung—acquired immunodeficiency syndrome	9.46e-05	0.00164	CbGeAlD
Glyburide—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.37e-05	0.000663	CcSEcCtD
Glyburide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.28e-05	0.000657	CcSEcCtD
Glyburide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	9.24e-05	0.0103	CbGpPWpGaD
Glyburide—Rash—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000651	CcSEcCtD
Glyburide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.00065	CcSEcCtD
Glyburide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000649	CcSEcCtD
Glyburide—Headache—Ritonavir—acquired immunodeficiency syndrome	9.14e-05	0.000647	CcSEcCtD
Glyburide—ABCA1—Folate Metabolism—IL2—acquired immunodeficiency syndrome	9.05e-05	0.0101	CbGpPWpGaD
Glyburide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.93e-05	0.000632	CcSEcCtD
Glyburide—ABCA1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	8.86e-05	0.00985	CbGpPWpGaD
Glyburide—Rash—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000627	CcSEcCtD
Glyburide—ABCB11—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	8.85e-05	0.00983	CbGpPWpGaD
Glyburide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000626	CcSEcCtD
Glyburide—Headache—Saquinavir—acquired immunodeficiency syndrome	8.8e-05	0.000623	CcSEcCtD
Glyburide—ABCB1—nervous system—acquired immunodeficiency syndrome	8.76e-05	0.00152	CbGeAlD
Glyburide—CPT1A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	8.7e-05	0.00967	CbGpPWpGaD
Glyburide—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.67e-05	0.000613	CcSEcCtD
Glyburide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000603	CcSEcCtD
Glyburide—ABCC3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	8.48e-05	0.00943	CbGpPWpGaD
Glyburide—Rash—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000598	CcSEcCtD
Glyburide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000597	CcSEcCtD
Glyburide—ABCB1—central nervous system—acquired immunodeficiency syndrome	8.44e-05	0.00146	CbGeAlD
Glyburide—Headache—Lamivudine—acquired immunodeficiency syndrome	8.39e-05	0.000594	CcSEcCtD
Glyburide—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.34e-05	0.00059	CcSEcCtD
Glyburide—ABCA1—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	8.1e-05	0.009	CbGpPWpGaD
Glyburide—ABCA1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	8.09e-05	0.00899	CbGpPWpGaD
Glyburide—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.96e-05	0.000563	CcSEcCtD
Glyburide—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	7.39e-05	0.00821	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	7.37e-05	0.00819	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	7.37e-05	0.00819	CbGpPWpGaD
Glyburide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	7.07e-05	0.00786	CbGpPWpGaD
Glyburide—ABCB1—brain—acquired immunodeficiency syndrome	6.7e-05	0.00116	CbGeAlD
Glyburide—ABCA1—Folate Metabolism—TNF—acquired immunodeficiency syndrome	6.59e-05	0.00732	CbGpPWpGaD
Glyburide—ABCA1—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	6.54e-05	0.00726	CbGpPWpGaD
Glyburide—ABCB1—lymph node—acquired immunodeficiency syndrome	6.47e-05	0.00112	CbGeAlD
Glyburide—ABCA1—Folate Metabolism—IL6—acquired immunodeficiency syndrome	5.32e-05	0.00591	CbGpPWpGaD
Glyburide—ABCA1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	5.23e-05	0.00582	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—TAT—acquired immunodeficiency syndrome	5.08e-05	0.00565	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—TAT—acquired immunodeficiency syndrome	5.08e-05	0.00565	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.74e-05	0.00527	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.55e-05	0.00505	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AGPS—acquired immunodeficiency syndrome	4.32e-05	0.0048	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.32e-05	0.0048	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	4.25e-05	0.00473	CbGpPWpGaD
Glyburide—ABCA1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.22e-05	0.00469	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	3.99e-05	0.00443	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	3.99e-05	0.00443	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.96e-05	0.0044	CbGpPWpGaD
Glyburide—CFTR—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.78e-05	0.0042	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.56e-05	0.00396	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.45e-05	0.00384	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	3.35e-05	0.00373	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.31e-05	0.00368	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—TAT—acquired immunodeficiency syndrome	3.14e-05	0.00349	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—TAT—acquired immunodeficiency syndrome	3.05e-05	0.00338	CbGpPWpGaD
Glyburide—ABCC9—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.73e-05	0.00303	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.67e-05	0.00297	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.67e-05	0.00297	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.62e-05	0.00291	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.62e-05	0.00291	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AGPS—acquired immunodeficiency syndrome	2.59e-05	0.00288	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.55e-05	0.00283	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	2.49e-05	0.00277	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.49e-05	0.00277	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	2.48e-05	0.00276	CbGpPWpGaD
Glyburide—SLCO2B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.48e-05	0.00275	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TAT—acquired immunodeficiency syndrome	2.38e-05	0.00265	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.18e-05	0.00242	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	2.11e-05	0.00235	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.07e-05	0.0023	CbGpPWpGaD
Glyburide—SLC15A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.07e-05	0.0023	CbGpPWpGaD
Glyburide—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.04e-05	0.00226	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	2.03e-05	0.00225	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AGPS—acquired immunodeficiency syndrome	2.02e-05	0.00225	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.99e-05	0.00221	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.99e-05	0.00221	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.93e-05	0.00215	CbGpPWpGaD
Glyburide—SLC15A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.92e-05	0.00214	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	1.87e-05	0.00207	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	1.8e-05	0.002	CbGpPWpGaD
Glyburide—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.78e-05	0.00198	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.76e-05	0.00196	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.74e-05	0.00193	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	1.64e-05	0.00182	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	1.61e-05	0.00179	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	1.61e-05	0.00179	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.59e-05	0.00176	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.58e-05	0.00176	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.54e-05	0.00171	CbGpPWpGaD
Glyburide—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.52e-05	0.00169	CbGpPWpGaD
Glyburide—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	1.51e-05	0.00168	CbGpPWpGaD
Glyburide—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.43e-05	0.00159	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.4e-05	0.00155	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.37e-05	0.00152	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	1.31e-05	0.00146	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	1.3e-05	0.00145	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	1.3e-05	0.00144	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.26e-05	0.0014	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.17e-05	0.0013	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.06e-05	0.00118	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.05e-05	0.00117	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.04e-05	0.00116	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.03e-05	0.00115	CbGpPWpGaD
Glyburide—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.01e-05	0.00113	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	9.96e-06	0.00111	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.77e-06	0.00109	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.72e-06	0.00108	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.32e-06	0.00104	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	9.09e-06	0.00101	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	8.87e-06	0.000986	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ALB—acquired immunodeficiency syndrome	8.87e-06	0.000985	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ALB—acquired immunodeficiency syndrome	8.87e-06	0.000985	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.86e-06	0.000985	CbGpPWpGaD
Glyburide—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	8.61e-06	0.000957	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	8.54e-06	0.000949	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	8.41e-06	0.000935	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	8.29e-06	0.000921	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.12e-06	0.000902	CbGpPWpGaD
Glyburide—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	7.95e-06	0.000884	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	7.73e-06	0.000859	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.72e-06	0.000858	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.55e-06	0.000839	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.3e-06	0.000812	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.25e-06	0.000806	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.05e-06	0.000783	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.03e-06	0.000781	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.95e-06	0.000772	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	6.85e-06	0.000762	CbGpPWpGaD
Glyburide—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	6.68e-06	0.000743	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.11e-06	0.000679	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ALB—acquired immunodeficiency syndrome	5.48e-06	0.000609	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	5.47e-06	0.000608	CbGpPWpGaD
Glyburide—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	5.45e-06	0.000606	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ALB—acquired immunodeficiency syndrome	5.31e-06	0.00059	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.92e-06	0.000546	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	4.65e-06	0.000517	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	4.33e-06	0.000481	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—acquired immunodeficiency syndrome	4.15e-06	0.000461	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.62e-06	0.000402	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.56e-06	0.000396	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	3.53e-06	0.000393	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	3.42e-06	0.00038	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.3e-06	0.000367	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	3.25e-06	0.000361	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.25e-06	0.000361	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	2.86e-06	0.000318	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	1.85e-06	0.000206	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.59e-06	0.000176	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.55e-06	0.000172	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.45e-06	0.000161	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	9.53e-07	0.000106	CbGpPWpGaD
